AOA
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice and help reduce patient mortality.
AOA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2020-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.aoadx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
24.5 M USD
Technology used in webpage:
Euro U.S. Server Location EmbedSocial
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Cognito Therapeutics
Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
NanoCellect Biomedical
NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.
Pleno
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Employees Featured
Founder
Investors List
Gore Range Capital
Gore Range Capital investment in Series A - AOA
LabCorp Venture Fund
LabCorp Venture Fund investment in Series A - AOA
Good Growth Capital
Good Growth Capital investment in Series A - AOA
Astia
Astia investment in Series A - AOA
The Helm
The Helm investment in Series A - AOA
RH Capital
RH Capital investment in Series A - AOA
LongeVC
LongeVC investment in Series A - AOA
VU Venture Partners
VU Venture Partners investment in Series A - AOA
Cancer Fund
Cancer Fund investment in Series A - AOA
Adaptive Capital Partners
Adaptive Capital Partners investment in Series A - AOA
Official Site Inspections
http://www.aoadx.com Semrush global rank: 7.89 M Semrush visits lastest month: 673
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AOA"
About Us – AOA DX
[email protected]. [email protected]. 6860 Broadway, Denver CO 80221. Follow. Instagram Linkedin Twitter. Website by Sungraphic ...See details»
AOA DX – Early cancer detection
[email protected]. 6860 Broadway, Denver CO 80221. Follow. Instagram Linkedin Twitter. Website by Sungraphic ...See details»
AOA - Crunchbase Company Profile & Funding
Contact Email [email protected] AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical …See details»
AOA Dx - LinkedIn
AOA Dx | 9,189 followers on LinkedIn. Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI | AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for ...See details»
Our Team – AOA DX
Oriana is a visionary leader in the field of women’s health and diagnostics. Recently honored in Inc’s 2022 Top 100 Female Founders for her work in ovarian cancer diagnosis, Oriana brings …See details»
AOA Dx: Blood Test for Early Detection of Ovarian …
Blood Test for Early Detection of Ovarian Cancer . Founded in 2020 by Alex Fisher, Anna Jeter, and Oriana Papin-Zoghbi, AOA Dx has 25 employees based in Denver, CO, USA.See details»
AOA Dx 2025 Company Profile: Valuation, Funding & Investors
AOA Dx General Information Description. Developer of an early disease detection platform designed to revolutionize early-stage cancer detection for women. The company offers a multi …See details»
Oriana Papin-Zoghbi - AOA Dx | LinkedIn
Oriana Papin-Zoghbi is the CEO and co-founder of AOA Dx. She is a visionary leader in… · Experience: AOA Dx · Education: Y Combinator · Location: New …See details»
AOA Inc - VentureRadar
"AOA Dx is revolutionizing early cancer detection with a groundbreaking platform focused on women's health. Utilizing GlycoLocateâ„¢, an AI-enabled technology, and AKRIVIS GDâ„¢, a …See details»
AOA Dx Inc | F6S
Aoadx.com About AOA Dx Inc AOA seeks to revolutionize early-stage diagnosis of ovarian cancer by developing a non-invasive ovarian cancer diagnostic liquid biopsy test that will improve …See details»
Meet Alex Fisher, Co-Founder of AOA Dx — OXONIAN VENTURES
Dec 8, 2023 Each year 8.5 million women are tested for suspected ovarian cancer in North America and Europe alone, representing a $6B market opportunity. Early diagnosis can save …See details»
AOA Dx Secures $17M to Advance Its Ovarian Cancer Diagnostic …
Oct 11, 2023 AOA Dx, a biotech startup based in the United States, has successfully raised $17M to accelerate the development of its liquid biopsy test for ovarian cancer. This round was …See details»
Team - AOA DX
At AOA Dx, she uses her technical expertise to support scientists across the organization in our mission to Transform Women’s Health. Megan earned her Masters in Comparative and …See details»
AOA Dx - Work in biotech
AOA Dx focuses on early cancer detection. Their unique GlycoLocate platform uses AI to detect gangliosides that may be used as tumor biomarkers to enable earlier detection and effective …See details»
AOA Dx Secures $20 Million in Funding to Revolutionize Early …
AOA Dx, a groundbreaking biotechnology company dedicated to advancing early-stage cancer detection specifically for women, is thrilled to announce the successful closing of a $20 million …See details»
Member Company Spotlight: AOA Dx is Aiming to Detect Ovarian …
Apr 20, 2022 AOA Dx Inc has partnered with a leading researcher at McGill University to develop the first early stage ovarian cancer liquid biopsy diagnostic test. The co-founders have …See details»
AOA Dx on LinkedIn: Congratulations to our CEO & Co-Founder …
She began her career as the fourth hire at a healthcare startup, where she played a pivotal role in establishing and developing the company's sales organization, and sold to Fortune 500 health …See details»
AOA Dx Co-Founders Oriana Papin-Zoghbi and Anna Jeter Named …
Sep 27, 2022 AOA Dx is proud to announce that co-founders Oriana Papin-Zoghbi and Anna Jeter have been named to Inc.’s 2022 Female Founders 100 List. Inc.’s fifth annual Female …See details»
AOA Dx — A Revolution in Ovarian Cancer Diagnosis
Mar 9, 2021 Developing a non-invasive ovarian cancer liquid biopsy diagnostic test that will improve clinical practice by diagnosing ovarian cancer…See details»
AOA Dx Demonstrates High Accuracy in AI-Powered Blood Test …
Apr 29, 2025 AOA Dx presented new data at the 2025 AACR Annual Meeting demonstrating high accuracy in early detection of ovarian cancer using its AI-powered multi-omic platform. In …See details»